| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
6e-13 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
8e-13 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
4e-09 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
6e-06 |
| mRNA |
betulinic acid |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-05 |
| mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
0.18 |
0.0002 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
| mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0006 |
| mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |